FdaApplication
ANDA 217449
Identifiers
- fda_app_no: ANDA217449
Properties
| Property | Value |
|---|---|
| applicant_name | NORWICH PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2026-06-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BALOXAVIR MARBOXIL | BALOXAVIR MARBOXIL | 40MG | TABLET;ORAL |
| BALOXAVIR MARBOXIL | BALOXAVIR MARBOXIL | 80MG | TABLET;ORAL |
2 products